New Drug Prevents Migraines Before They Start

Wochit - May 18, 2018
The FDA approved a new migraine drug on Thursday.

Aimovig, known generically as erenumab, is the first drug shown to stop migraine headaches before they start.

The drug would be approved for patients who have tried other drugs and found no relief.

In studies, it did not entirely prevent migraines, but reduced their frequency.

FDA's approval means the drug may soon be available under prescription. It should also be paid for by health insurance. The drug's maker, Amgen, said U.S.

list price is for the once monthly self-injection treatment will be $575 per month or $6,900 annually..


Recent related news

(Reuters) - Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug in a new class designed to prevent migraine headaches in...
3 days ago • Reuters

Number of the day $178 billion That’s how much American companies spent repurchasing shares during the first quarter, topping a record set in the third quarter...
2 days ago • SFGate

Recent related videos

Bloomberg Politics -   β–Ά  01:33

Wochit -   β–Ά  00:40

You might like